ProfessorLeigh Blizzard

Adjunct Professor

Menzies Institute for Medical Research

  • Adjunct Professor
    Menzies Institute for Medical Research
  • +61 3 6226 7704 (Fax)
  • +61 3 6226 7719 (Work)
  • Menzies Institute for Medical Research, Menzies Institute for Medical Research, Hobart CBD Campuses, TAS

FUNDED PROJECTS

  • GRANT
    Improving cardiovascular health through increased transport-related physical activity: A co-designed randomised controlled trial
    1 Jul 2022 - 31 Dec 2025
    People funded by this grant:
    • Cleland V,
    • Blizzard L,
    • Jose K,
    • Greaves S,
    • Timperio A
    Project Total: $787,664; Regular physical activity plays a key role in cardiovascular disease and stroke prevention, yet over one third of Australians are insufficiently active. This project aims to establish the impact on physical activity of a novel incentives-based strategy to increase public transport use through a single-blinded parallel group randomised controlled trial. Findings will provide public health and transport authorities with evidence to inform decisions around the use of incentives-based strategies. Funded by: Medical Research Future Fund - Grant - Cardiovascular Health Mission ($767,132); Deakin University ($20,532); University of Tasmania.
  • GRANT
    InforMS - an electronic patient-driven health care model with digital biomarker monitoring that improves the clinical care of people with MS
    1 Oct 2020 - 30 Sep 2027
    People funded by this grant:
    • van der Mei I,
    • Butzkueven H,
    • Taylor B,
    • Palmer A,
    • Blizzard L
    Project Total: $1,167,815; Multiple Sclerosis (MS) is a high cost and high burden neurological disease. Problem: there are many disease-modifying therapies available, so clinicians can theoretically switch treatments rapidly based on disease activity and side-effects. Yet this proves difficult when data on these is infrequently collected (currently 1-2 times a year) and is insensitive to fluctuations between visits. Solution: modern computing technologies (mobile apps, wearables) are changing the way health is monitored throughout medicine. We are enabled to collect more data, more accurately, and more frequently, and to share it more easily. If we could effectively harness such new monitoring technologies for MS, clinicians could be supported with objective, prospectively collected, frequently measured, change-sensitive data. Proposed research: we will create an electronic patient-centred health care system, InforMS, that becomes a one-stop-shop? management system for people with MS. It visualises patient-reported data, allows daily tracking and uploading of data from smartphones and wearable sensors, and allows sharing with clinicians via print, email, third-party access and via MSBase: the most widely used clinician registry worldwide. For clinical care, it would (1) enable timelier changes to treatments, and (2) provide greater confidence that treatments work. For patient self care, it would (3) empower people with MS to take a central role in managing their disease, and (4) activate them to collect novel time-sensitive data. For research, it would (5) deliver powerful annual trend data to enhance MS research. This is a paradigm shift in MS care and research. We already have a prototype of InforMS, developed together with end-users. In this proposal, we will add several key functionalities, roll out the full InforMS system within a registry of ~3,000 people with MS, and follow participants over time to test and optimise the system in practice. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($1,535,630); Multiple Sclerosis Research Australia Ltd ($400,000); University of Tasmania.
  • GRANT
    PISTACHIO - The Primary Trauma Care Course Impact and Outcome study in Vietnam
    1 Jan 2019 - 25 Nov 2023
    People funded by this grant:
    • Nelson M,
    • Tran V,
    • Blizzard L,
    • Skinner M,
    • Palmer A
    Project Total: $150,000; A before and after study in 2 Vietnamese hospitals of the effectiveness of a trauma management course for the reduction of morbidity and mortality of road trauma in that country. Funded by: Elphinstone Group - Donation ($150,000); University of Tasmania.
  • GRANT
    Health by Stealth: Increasing Physical Activity through Active Travel in Tasmania
    1 Jun 2018 - 30 Jun 2022
    People funded by this grant:
    • Cleland V,
    • Ball K,
    • Blizzard L,
    • Greaves S,
    • Jose K
    Project Total: $282,362; We are facing a global inactivity crisis. Participation in recommended amounts of physical activity (PA) has remained stagnant since the 1980s, indicating limited population-level impact of strategies to promote PA. A shift in focus from leisure-time to transport-related PA holds promise as an attractive but under-exploited opportunity to support individuals to incorporate more activity into daily life. Healthy transport options - walking, cycling and public transport - are critical social determinants of health, by reducing traffic accidents, increasing social contact, reducing air pollution, and increasing exercise. Improving our understanding of travel behaviours and identifying strategies to increase use of healthy transport options have been identified by our three highly engaged Tasmanian Partner Organisations as important priorities. This project seeks to generate evidence with service providers, state government and local government authorities to support decision-making and resource allocation in relation to increasing active and public transport use. Working closely with our Partners, we will analyse data from existing data sources to better understand Tasmanians' travel behaviours and the factors that influence these, by evaluating the effectiveness of two 'realworld' fiscal strategies aiming to increase active and public transport use, and by developing and implementing a knowledge transfer strategy to ensure findings are effectively communicated. This project will generate some of the first evidence internationally about the effectiveness of fiscal strategies to increase active and public transport use, and will provide crucial information to directly impact the work of service providers,decision makers, policy-makers and practitioners. By identifying effective strategies to increase PA through active transport, the implications of this project have the potential to make major direct health, social, environmental and economic impacts globally. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($544,724); Department of Health and Human Services Tasmania ($10,000); University of Tasmania.
  • GRANT
    REDucing Delays In aneurysmal Subarachnoid Haemorrhage: the REDDISH study
    1 Jan 2018 - 30 Dec 2021
    People funded by this grant:
    • Gall S,
    • Thrift A,
    • Chandra R,
    • Stirling C,
    • Kinsman L
    Project Total: $436,023; Aneurysmal subarachnoid haemorrhage (aSAH) is a rare form of stroke that kills up to 40% of sufferers within 1 month. Outcome can be improved through quickly receiving medical care but many people do not and this likely contributes to the poor outcomes. The REDucing Delays In Subarachnoid Haemorrhage (REDDISH) study will look at cases of aSAH across Tasmanian and Victoria so that we can understand the factors that contribute to delays in treatment and ultimately improve outcomes. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($872,046); University of Tasmania.
  • GRANT
    Effectiveness of imaging pathways for CVD epidemics of the elderly
    1 Dec 2017 - 30 Nov 2021
    People funded by this grant:
    • Marwick T,
    • Chew D,
    • Kaye D,
    • Negishi K,
    • Stocks N
    Project Total: $703,875; Cardiovascular imaging, especially echocardiography, is a cornerstone of modern cardiology; guidelines stipulate the use of echocardiography to inform therapeutic intervention in heart failure and valvular heart disease. However, there is also a risk of overuse, and in contrast to North America, where the growth of imaging has been controlled over the last decade, use in Australia continues to grow at ~10% per year. The dependence on imaging is greater in the cardiovascular disease (CVD) epidemics of the elderly (atrial fibrillation [AF], aortic stenosis [AS] and heart failure [HF]) than in other diagnoses. Not only are large numbers of tests being done currently, but the growth of these conditions will magnify the problem over the coming years. Failure to manage the hospitalisation, device and procedural costs for treatment of these new CV epidemics can be linked to shortcomings in the practice of CV imaging. The need for ongoing surveillance that is heavily dependent on cardiac imaging will introduce new complexities around imaging quality. Despite the expenditure of ~$1 billion/year on CV imaging in Australia, there is little evidence of value. The Partnership will link researchers with providers and imaging industry to improve all steps of the imaging 'value chain' - ranging from the selection of suitable patients to the quality of interpretation. These studies will improve appropriate selection for testing, quality control and integration of decision-making with imaging. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project; University of Tasmania.
  • GRANT
    Preclinical Development of Neuropeptide Y for the Treatment of Motor Neuron Disease
    16 Jun 2017 - 30 Apr 2021
    People funded by this grant:
    • Dickson T,
    • Blizzard C,
    • Pebay A,
    • Walker A,
    • Blizzard L
    Project Total: $936,572; Motor Neuron Disease (MND) is a rapidly progressing neurodegenerative disease. There are no cures and no effective treatments for MND, with people diagnosed having a median survival of only three years from symptom onset. Not knowing the cause of MND or how it progresses through the CNS have been immense barriers to the development of effective therapeutics. We have reached a critical time in MND research. Our research team has been dedicated to researching the mechanism of MND for the last ten years. We are now poised to transition my teams research efforts from determining the cause of this disease to using this knowledge to develop treatments. A critical pathway that our work and others have shown is key to MND is altered network excitability and subsequent excitotoxicity in the cortex. We have recent published and preliminary data that identifies that a critical potential point of intervention in this pathway is via the subclass of inhibitory cells that express neuropeptide Y (NPY). The overarching Aim for this Cure for MND Translational Research Grant is to now target this pathway to develop a treatment. By performing this world-first preclinical trial we will reveal further aspects of disease pathogenesis. Positive outcomes from these trials will identify a candidate compounds for progression to a human trial for the treatment of MND. Funded by: FightMND - Grant-Translational Research Grant ($936,572); University of Tasmania ($50,000).
  • GRANT
    Cardiometabolic risk trajectories from childhood to midlife: finding pathways to better health
    1 Jan 2017 - 31 Dec 2020
    People funded by this grant:
    • Venn A,
    • Marwick T,
    • Blizzard L,
    • Magnussen C,
    • Gall S
    Project Total: $1,531,986; Using data from a large cohort of Australian children followed for over 30 years, this study will investigate how weight status and physical fitness from childhood to adulthood determine early markers of cardiovascular disease and type 2 diabetes (cardiometabolic disease) in midlife. It will provide much needed evidence to address the high prevalence of cardiometabolic disease risk factors in young Australians through better targeted disease prevention and early clinical intervention strategies. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($3,063,972); University of Tasmania.
  • GRANT
    Does treating multiple sclerosis alter long-term disease outcomes? a natural history study
    1 Jan 2016 - 30 Jun 2018
    People funded by this grant:
    • Taylor B,
    • van der Mei I,
    • Palmer A,
    • Blizzard L,
    • Butzkueven H
    Project Total: $180,000; A natural history study of MS outcomes between a treated (Australian) versus untreated NZ population to study the long-term effects of MS disease modifying drugs. This is a clinical epidemiological project. Funded by: Multiple Sclerosis Australia - Grant-Project ($180,000); University of Tasmania.
  • GRANT
    Case-control study in Primary Progressive MS: Are the risk factors the same as for people with RRMS onset and can we identify new ones?
    1 Jan 2015 - 31 Jul 2017
    People funded by this grant:
    • van der Mei I,
    • Taylor B,
    • Ponsonby A,
    • Lucas R,
    • Simpson JR S
    Project Total: $142,000; Examining risk factors of disease by comparing cases with a disease to healthy controls has been critical in understanding the aetiology of diseases. In MS, for example, important progress has been made through the epidemiological findings that cases were more likely to have had infectious mononucleosis, have high anti-EBNA IgG titres, and have low sun exposure levels. These findings resulted in a large body of laboratory work focusing on the mechanisms behind these observations. We have previously conducted epidemiological case-control studies on MS, but the number of people with PPMS was always too low to conduct a sub-analysis to examine whether the risk factors that we identified were also important in those with PPMS. We now propose to conduct a case-control of PPMS in a very cost-effective way, by using the data already collected on a large sample of healthy controls (n=558) from the Ausimmune study. We aim to collect the same data from a sample of cases with PPMS in Australia and compare that to the controls of the Ausimmune study. Moreover, the longer-term vision is that this data will form the basis for a prospective longitudinal study, where the cases with PPMS will be followed over time, in order to examine factors that are associated with the progression of MS. This will then be important for identifying possible treatments in MS for people with PPMS. Hypotheses * Established risk factors in MS, including low sun exposure, infectious mononucleosis, smoking, high anti-EBV-EBNA IgG and HLA-DR15 genotype are associated with an increased risk of PPMS onset. * Low parity, lack of younger sibling exposure and exposure to livestock are associated with an increased risk of PPMS. * People with PPMS have a higher EBV DNA load in whole blood and altered EBV serology compared to people with a RRMS onset. Funded by: Multiple Sclerosis Australia - Grant-Project ($142,000); University of Tasmania.
  • GRANT
    Coronary Artery calcium score: Use to Guide management of Hereditary Coronary Artery Disease (CAUGHT-CAD)
    1 Jan 2015 - 31 Dec 2020
    People funded by this grant:
    • Marwick T,
    • Nicholls S,
    • Watts G,
    • Worthley S,
    • Tonkin A
    Project Total: $2,802,386; Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($5,604,772); University of Tasmania.
  • GRANT
    Bariatric surgery in Tasmanian public hospitals: investigating health service use, costs, and policy options
    1 Jul 2014 - 30 Jun 2016
    People funded by this grant:
    • Venn A,
    • Wilkinson S,
    • Greenaway T,
    • Hensher M,
    • Palmer A
    Project Total: $8,088; Bariatric surgery is considered an effective treatment for significant obesity-related illness but it is difficult to access in Australian public hospitals. By describing Tasmanian public patients' characteristics, clinical pathways, costs and outcomes this project will support better informed decision-making about Tasmanian public hospital services for clinically obese patients. Funded by: Royal Hobart Hospital Research Foundation - Grant-Starter ($8,088); University of Tasmania ($45,000).
  • GRANT
    Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options
    1 Jun 2014 - 7 Feb 2025
    People funded by this grant:
    • Venn A,
    • Palmer A,
    • Ezzy D,
    • Blizzard L,
    • Nelson M
    Project Total: $839,027; About 1 in 20 Tasmanians are severely obese. Bariatric surgery can improve health for individuals with severe obesity but access to surgery is poor for most public patients. This study will investigate the pathways of patients referred for bariatric surgery in the Tasmanian public and private hospital systems to better understand the demand for surgery, the health outcomes, and costs associated with these different pathways. The findings will inform public policy and resource allocation. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($1,288,054); Department of Health and Human Services Tasmania ($150,000); Department of Premier and Cabinet ($45,000); University of Tasmania.
  • GRANT
    Guidance of Heart Failure Management Programs by Risk Assessment
    1 Sep 2013 - 31 Aug 2019
    People funded by this grant:
    • Marwick T,
    • Venn A,
    • Sanderson K,
    • Nelson M,
    • Palmer A
    Project Total: $1,422,739; The aims of this project are to reduce Heart Failure (HF) admissions and costs in Tasmania by: i) using data linkage to identify locations where community service delivery should be targeted, and to evaluate current performance in HF readmission across the State; ii) developing a risk algorithm for HF readmission, including psychosocial determinants; iii) using i) and ii) devising a novel means of providing a disease management program (DMP), titrated to risk assessment, with physiologic assessment used to guide the management of the highest risk patients; iv) developing a clinical trial to define the merits of this approach; v) evaluating the cost-effectiveness of this intervention; vi) presentation of educational activities with community-based providers. A successful intervention is likely to be sustainable. As HF readmissions in Tasmania cost ~4550 bed days/y, the investment in this grant (~$1/2m/y) could be reproduced by a 50% reduction of readmissions. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($1,885,478); Primary Health Tasmania ($480,000); University of Tasmania.
  • GRANT
    Effect of vitamin D supplementation of the currently used dosage regime of 400 IU/d on vitamin D levels in infants
    1 Jan 2013 - 31 Mar 2014
    People funded by this grant:
    • Jones G,
    • Lim B,
    • Dargaville P,
    • van der Mei I,
    • Winzenberg T
    Project Total: $22,716; Funded by: Royal Hobart Hospital Research Foundation - Grant-Clinical Research ($22,716); University of Tasmania.
  • GRANT
    The role of environmental and genetic factors in progression of multiple sclerosis
    1 Jan 2013 - 31 Dec 2017
    People funded by this grant:
    • Taylor B,
    • van der Mei I,
    • Lucas R,
    • Blizzard L,
    • Coulthard A
    Project Total: $945,084; Much is known regarding the factors that increase the risk of developing multiple sclerosis. However there is little data regarding the importance of these and other factors on the rate of progression of MS. Once the diagnosis of MS is made one of the critical issues for patients and treating physicians is; what will happen now? As there are currently no established modifiable risk factors for MS progression, this project aims to delineate potentially modifiable risk factors for MS progression. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Project ($1,890,168); University of Tasmania.
  • GRANT
    The efficacy of vitamin D supplementation in early life on bone health: Pilot of a double-blind randomized controlled trial
    1 Oct 2012 - 31 Dec 2013
    People funded by this grant:
    • van der Mei I,
    • Gibson R,
    • Winzenberg T,
    • Dargaville P,
    • Blizzard L
    Project Total: $27,920; Funded by: The Marian and EH Flack Trust - Grant-Project ($27,920); University of Tasmania.
  • GRANT
    Mild cognitive impairment, gait and falls - A population-based study
    18 Sep 2012 - 17 Sep 2013
    People funded by this grant:
    • Callisaya M,
    • Srikanth V,
    • Blizzard L,
    • Wood A
    Project Total: $18,181; Funded by: Royal Hobart Hospital Research Foundation - Grant-Clinical Research ($18,181); University of Tasmania.
  • GRANT
    The Cholecalciferol Intervention to Prevent Respiratory Infections Study (CIPRIS)
    1 Sep 2012 - 31 Aug 2013
    People funded by this grant:
    • Simpson JR S,
    • Taylor B,
    • Stewart N,
    • van der Mei I,
    • Blizzard L
    Project Total: $6,335; Funded by: The Select Foundation - Grant-Small Grants Scheme ($6,335); University of Tasmania.
  • GRANT
    Building research capacity in epidemiological studies of chronic disease and injury
    1 Jan 2012 - 31 Dec 2015
    People funded by this grant:
    • Blizzard L
    Project Total: $432,568; Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Fellowship-Career Development ($865,136); University of Tasmania.
  • GRANT
    Examining the role of lipids in the progression of MS in a prospective cohort study
    1 Jan 2012 - 31 Dec 2013
    People funded by this grant:
    • van der Mei I,
    • Taylor B,
    • Blizzard L,
    • Ponsonby A,
    • Dwyer T
    Project Total: $60,000; Funded by: Multiple Sclerosis Australia - Grant-Project ($60,000); University of Tasmania.
  • GRANT
    The role of Acanthamoeba in Intensive Therapy Ward Infections
    11 Mar 2011 - 11 Mar 2012
    People funded by this grant:
    • Bradbury R,
    • Blizzard L
    Project Total: $9,090; Funded by: Royal Hobart Hospital Research Foundation - Grant-Research ($9,090); University of Tasmania.
  • GRANT
    Breathe Well: a Centre for Research Excellence in chronic respiratory diseases and lung ageing
    1 Jan 2011 - 30 Apr 2016
    People funded by this grant:
    • Walters H,
    • Wood-Baker R,
    • Reid D,
    • Dharmage S,
    • Robinson A
    Project Total: $2,439,690; Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Centres of Clinical Research Excellence ($4,879,380); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Connecting Care Evaluation - Chronic disease action framework
    1 Jan 2010 - 1 Jun 2011
    People funded by this grant:
    • Bell E,
    • Blizzard L
    Project Total: $31,573; This project will identify indicators, consolidate and tabulate indicators, QCA analysis of indicators, refine and test the findings and produce set theoretic findings. Funded by: Department of Health and Human Services Tasmania ($31,573); University of Tasmania.
  • GRANT
    Improving health and wellbeing in the Tasmanian State Service workforce
    1 Jan 2010 - 31 Dec 2015
    People funded by this grant:
    • Venn A,
    • Sanderson K,
    • Blizzard L,
    • Taylor R,
    • Wood-Baker R
    Project Total: $916,250; Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($1,712,500); Department of Premier and Cabinet ($60,000); University of Tasmania.